[2-(4,6-Dimethoxypyrimidin-2-yl)oxy-5-methylphenyl]-(4-methylphenyl)methanone

ID: ALA476733

Max Phase: Preclinical

Molecular Formula: C21H20N2O4

Molecular Weight: 364.40

Molecule Type: Small molecule

Associated Items:

Representations

Canonical SMILES:  COc1cc(OC)nc(Oc2ccc(C)cc2C(=O)c2ccc(C)cc2)n1

Standard InChI:  InChI=1S/C21H20N2O4/c1-13-5-8-15(9-6-13)20(24)16-11-14(2)7-10-17(16)27-21-22-18(25-3)12-19(23-21)26-4/h5-12H,1-4H3

Standard InChI Key:  IEBFUVHCIRXOHE-UHFFFAOYSA-N

Associated Targets(non-human)

Rattus norvegicus (775804 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
Pla2g1b Phospholipase A2 group 1B (27 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
Mus musculus (284745 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Molecule Features

Natural Product: NoOral: NoChemical Probe: NoParenteral: No
Molecule Type: Small moleculeTopical: NoFirst In Class: NoBlack Box: No
Chirality: NoAvailability: NoProdrug: No

Drug Indications

MESH IDMESH Heading EFO IDsEFO TermsMax Phase for IndicationReferences

Mechanisms of Action

Mechanism of ActionAction Typetarget IDTarget NameTarget TypeTarget OrganismBinding Site NameReferences

Properties

Molecular Weight: 364.40Molecular Weight (Monoisotopic): 364.1423AlogP: 4.13#Rotatable Bonds: 6
Polar Surface Area: 70.54Molecular Species: NEUTRALHBA: 6HBD: 0
#RO5 Violations: 0HBA (Lipinski): 6HBD (Lipinski): 0#RO5 Violations (Lipinski): 0
CX Acidic pKa: CX Basic pKa: 0.05CX LogP: 5.59CX LogD: 5.59
Aromatic Rings: 3Heavy Atoms: 27QED Weighted: 0.61Np Likeness Score: -0.92

References

1. Venu TD, Khanum SA, Firdouse A, Manuprasad BK, Shashikanth S, Mohamed R, Vishwanth BS..  (2008)  Synthesis and anti-inflammatory activity of 2-(2-aroylaroxy)-4,6-dimethoxy pyrimidines.,  18  (15): [PMID:18621525] [10.1016/j.bmcl.2008.06.061]

Source